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DefensinsThe NF-kB family of transcription factors regulates important biological functions including cell growth, sur-
vival and the immune response. We found that Human Papillomavirus type 16 (HPV-16) E7 and E6/E7 pro-
teins inhibited basal and TNF-alpha-inducible NF-kB activity in human epithelial cells cultured from the
cervical transformation zone, the anatomic region where most cervical cancers develop. In contrast, HPV-
16 E6 regulated NF-kB in a cell type- and cell growth-dependent manner. NF-kB inﬂuenced immortalization
of cervical cells by HPV16. Inhibition of NF-kB by an IkB alpha repressor mutant increased colony formation
and immortalization by HPV-16. In contrast, activation of NF-kB by constitutive expression of p65 inhibited
proliferation and immortalization. Our results suggest that inhibition of NF-kB by HPV-16 E6/E7 contributes
to immortalization of cells from the cervical transformation zone.
© 2012 Elsevier Inc. All rights reserved.Introduction
The major risk factor for cervical cancer is infection with a subset
of high risk human papillomaviruses (HPV) including HPV type 16
(HPV-16). The HPV-16 E6 and E7 genes are important as they are se-
lectively retained and expressed in most cervical cancers and they are
sufﬁcient to immortalize human epithelial cells (Munger et al., 1989).
The E7 protein inactivates the retinoblastoma tumor suppressor pro-
tein and promotes cell cycle progression (Jones et al., 1997). E6 stim-
ulates degradation of the p53 tumor suppressor protein (Scheffner
et al., 1990) and contributes to immortalization by activating hTERT,
the catalytic subunit of telomerase (Klingelhutz et al., 1996). In addi-
tion to effects on cell proliferation, HPV E6 and E7 proteins interfere
with speciﬁc components the innate immune response (Chang and
Laimins, 2000; Georgopoulos et al., 2000; Hasan et al., 2007; Nees
et al., 2001; Ronco et al., 1998; Woodworth and Simpson, 1993)
which may contribute to persistent HPV infection. These interactions
are important because persistent infection with high risk HPVs and
immortalization of epithelial cells are early events in the develop-
ment of cervical cancer.dworth).
rights reserved.The NF-kB family of transcription factors regulates multiple bio-
logical functions. NF-kB serves a major role in the inﬂammatory and
innate immune responses by stimulating expression of cytokines, cy-
tokine receptors, and histocompatibility genes (Hayden et al., 2006).
Several viruses have evolved mechanisms to regulate NF-kB, and acti-
vation or inhibition contributes to virus persistence, replication, or
transformation of infected cells (Hiscott et al., 2006). NF-kB is active
in epithelial cells of the cervix (Nees et al., 2001), and epithelial
cells are an important component of the innate immune system.
NF-kB can function as an oncogene through its ability to stimulate
cell proliferation and survival. NF-kB is constitutively activated in sev-
eral human cancers (Karin, 2006; Li et al., 2005), including cancer of
the cervix (Branca et al., 2006; Nair et al., 2003; Prusty et al., 2005).
Activation of NF-kB promotes malignant development and progres-
sion in several animal models (Erez et al., 2010; Greten et al., 2004;
Pikarsky et al., 2004) and NF-kB has been proposed to be an impor-
tant link between chronic inﬂammation and cancer (Karin, 2009). In-
hibition of NF-kB is a potential target for cancer therapy and
chemoprevention (Baud and Karin, 2009). However, NF-kB can also
act as a tumor suppressor in epidermal squamous cell carcinoma
(Dajee et al., 2003; van Hogerlinden et al., 1999) and liver cancer
(Maeda et al., 2005). We are interested in whether HPV infection al-
ters NF-kB activation in human cervical epithelial cells and whether
alterations in NF-kB contribute to cervical carcinogenesis.
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Fig. 2. Immortalization by HPV-16 decreases NF-kB activity and expression of β-defensins
in cervical cells. A. Relative NF-kB activity in conﬂuent cultures of primary cells derived
from: endocervix (endo), transformation zone (TZ), ectocervix (ecto), and ﬁve immortal
cell lines derived from either TZ (1, 2, and 3) or endocervix (4 and 5). Each bar represents
themeanof at least three reporter gene experiments±standard error. Asterisks are values
that differ statistically (p≤0.05) from TZ cells (1, 2, 3) or endocervical cells (4 and 5).
Crosses are values that differ signiﬁcantly fromectocervical cells. B. Real time PCR analyses
of expression of RNAs for β-defensins in conﬂuent HPV-immortalized cervical cells with
reduced NF-kB activity (average of lines 2 and 3 from TZ and lines 4 and 5 from endocer-
vix) expressed as percentage of normal cervical cells (average of ﬁve normal cultures).
Each bar represents the mean of 4 different immortal cell lines±standard error. Asterisks
show values that differ statistically (p≤0.05) from normal cells.
54 E.R. Vandermark et al. / Virology 425 (2012) 53–60The HPV-16 E6 and E7 proteins regulate NF-kB, but conﬂicting ev-
idence exists as to whether they stimulate (Hussain et al., 2011;
James et al., 2006; Nees et al., 2001; Xu et al., 2010) or suppress acti-
vation (Havard et al., 2002, 2005; Huang and McCance, 2002; Perea
et al., 2000; Spitkovsky et al., 2002). In this regard, the NF-kB activa-
tion pathway is dependent of the type of cell and context of the sig-
nal. Our ﬁrst goal was to clarify how HPV-16 E6 and E7 proteins
regulate NF-kB in epithelial cells cultured from the cervical transfor-
mation zone. These cells are the natural target for HPV infection and
the progenitors for most cervical cancers (Burghardt and Ostor,
1983). The importance of NF-kB in the regulation of growth and im-
mortalization of HPV-16 infected cervical cells is unclear. Our second
goal was to determine whether inhibition or activation of NF-kB reg-
ulates cell proliferation or immortalization of epithelial cells from the
cervical transformation zone by HPV-16.
Results
Immortalization decreases NF-kB activity
We examined activation of NF-kB in human epithelial cells isolat-
ed from three anatomic regions of the cervix including ectocervix,
endocervix and the transformation zone (Fig. 1A). Most cervical can-
cers arise within the transformation zone (Burghardt and Ostor,
1983) where the columnar endocervical epithelium is replaced by
metaplastic squamous epithelium. Cells cultured from each region
demonstrated different morphology (Fig. 1B) and grewwell in mono-
layer culture. We used a reporter gene assay to compare NF-kB activ-
ity in the normal cells and ﬁve HPV-16-immortalized cervical cell
lines (three from transformation zone cells, two from endocervical
cells) that were derived after transfection with the complete HPV-
16 genome. NF-kB activity was signiﬁcantly higher (p≤0.05) in
early passage, unimmortalized cells from endocervix or the transforma-
tion zone than in ectocervical cells (Fig. 2A). NF-kB activity decreased
signiﬁcantly (p≤0.05) in each of the ﬁve HPV-16-immortalized cell
lines compared to their respective normal cell type. We also examinedA
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Fig. 4. HPV-16 E6 and E7 genes regulate NF-kB differently in cervical transformation
zone cells (TZ) and foreskin cells maintained as growing or conﬂuent cultures. NF-kB
activation is shown relative to control (vector=1) in cultures of cervical cells (top)
and foreskin keratinocytes (bottom) that were 95% conﬂuent (growing slowly) or
growing rapidly (less than 50% conﬂuent)±1.0 nM TNF-α for 24 h. Bars indicate the
mean±standard error of at least 3 experiments using cells from different donors,
and asterisks are values that differ statistically (P≤0.05) from the control (vector).
1.5 untreated
55E.R. Vandermark et al. / Virology 425 (2012) 53–60decreased (p≤0.05) in immortal cells (two from transformation zone
and two from endocervix) with respect to normal cervical cells
(Fig. 2B). Thus, immortalization of cervical cells decreased NF-kB activ-
ity and expression of speciﬁc NF-kB-responsive genes.
The HPV-16 E7 protein decreases NF-kB activity
The HPV-16 E6 and E7 proteins are necessary and sufﬁcient for
immortalization of primary epithelial cells. We examined whether
E6, E7 or both were required for down regulation of NF-kB in epithe-
lial cells cultured from the cervical transformation zone. Cultures of
normal human cervical cells were infected with retroviruses encoding
HPV-16 E6, E7, E6/E7 or vector only (control) and examined for NF-kB
activity using a reporter gene assay. The results from a typical exper-
iment are shown in Fig. 3. NF-kB activity was signiﬁcantly higher
(p≤0.05) in slowly growing conﬂuent cultures than in rapidly grow-
ing sub conﬂuent cultures. Treatment with TNF-α for 24 h induced
NF-kB under both conditions (Fig. 3). The E7 and E6/E7 proteins sig-
niﬁcantly inhibited baseline NF-kB as well as TNF-α-induced NF-kB
activation. However, the effects of E6 were variable (see below).
Because the activity of NF-kB varied in cells cultured from differ-
ent individuals and in different experiments, we performed four inde-
pendent experiments using cells from the cervical transformation
zones of different donors. Although our work focused on transforma-
tion zone cells, other cell types (endocervical, ectocervical, foreskin
and oral epithelial cells) were used for comparison and to examine
cell-type speciﬁc affects on NF-kB activation. The results of each ex-
periment were normalized with respect to the internal control (vec-
tor only=1). In both foreskin and cervical cells, the E7 protein
reduced baseline NF-kB as well as TNF-α-inducible activity compared
to the control (Fig. 4). To examine the mechanism for down regula-
tion of NF-kB, we used an HPV-16 E7 mutant that is defective in the
ability to bind the retinoblastoma (Rb) protein (Edmonds and
Vousden, 1989). Infection of cervical transformation zone cells with
retroviruses encoding this mutant did not decrease basal or TNF-α-
inducible NF-kB (Fig. 5), indicating that the integrity of the Rb binding
site on E7 is necessary for its ability to inhibit NF-kB.
The HPV-16 E6 protein regulates NF-kB in a cell-type and cell-growth de-
pendent manner
In contrast to HPV-16 E7, the E6 protein did not signiﬁcantly alter
NF-kB activity in conﬂuent cultures of cells from the cervical transfor-
mation zone or foreskin (Fig. 4, left). However, E6 increased baseline
and TNF-α-inducible NF-kB by two- to three-fold in rapidly growing
foreskin cells (Fig. 4, bottom right). The effect of E6 in proliferating0
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Fig. 3. HPV-16 E6 and E7 proteins regulate baseline and TNF-α-inducible NF-kB in cells
from cervical transformation zone. Typical reporter gene experiment showing relative
NF-kB activity in cells infected with HPV-16 retroviruses and maintained under differ-
ent culture conditions including 95% conﬂuence (conﬂuent) or less than 50% conﬂu-
ence (growing)±1.0 nM TNF-α for 24 h. Bars equal the mean of 3 replicate wells
±standard error and asterisks are values that differ statistically (p≤0.05) from the
control (vector) within each of the four culture conditions.foreskin cells was dominant over E7 because E6/E7 together also in-
creased NF-kB (Fig. 4, bottom right). In addition, the effect of E6
was dependent on cell type because E6 or E6/E7 did not signiﬁcantly
induce NF-kB in cells from the cervical transformation zone (Fig. 4,
top).
The HPV-16 E6/E7 proteins decrease NF-kB in different types of epithelial
cells
HPV-16 infects epithelia from different anatomic sites. Therefore,
we compared effects of HPV-16 E6/E7 proteins on cells derived from
different types of epithelia including ectocervical, foreskin, oral, and
transformation zone epithelium. Infectionwith E6/E7 reduced NF-kB
activity consistently in conﬂuent cultures of oral epithelial cells,
foreskin cells and transformation zone cells (Fig. 6) but not in0.0
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Fig. 5. Down regulation of NF-kB by HPV-16 E7 depends upon inactivation of the Rb
tumor suppressor protein. NF-kB activity relative to control (vector=1) in conﬂuent
cervical cells from the transformation zone after infection with HPV-16 retroviruses
that encode either wild type E7 protein or the p24gly E7 mutant (E7 mut) that is defec-
tive for binding the retinoblastoma tumor suppressor protein. Each bar represents the
mean±standard error of at least 3 experiments using cells from different donors. As-
terisks represent values that are statistically different (p≤0.05) than the control
(vector=1).
01
2
ecto HKC oral TZ
growing
confluent
*
*
*
* **N
F-
kB
 a
ct
iv
ity
re
la
tiv
e 
to
 c
on
tro
l
*
Fig. 6. HPV-16 E6/E7 expression alters NF-kB activity relative to control (vector=1) in
cultures of growing or conﬂuent cells from ectocervical epithelium (ecto), foreskin ep-
ithelium (HKC), oral epithelium, or the transformation zone (TZ). Bars indicate the
mean±standard error from at least 3 independent experiments and asterisks are
values that differ statistically (p≤0.05) from control.
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Fig. 7. Genetic manipulation of NF-kB inﬂuences growth of HPV-16 expressing cervical
transformation zone cells. A. Transfection of cervical cells with a p65 expression con-
struct or the IkBαm super repressor mutant activates or inhibits relative NF-kB activity,
respectively. B. Cotransfection of P65 or IkBαmwith HPV-16 DNA inhibits or stimulates
colony formation, respectively in normal cervical cells from the transformation zone. C.
Measurement of colony forming ability relative to control (vector=1) after cotransfec-
tion of normal cells with HPV-16 DNA (HPV-16) and either vector, p65 or IkBαm, after
cotransfection of E6/E7 retrovirus-infected cells (E6/E7), or after cotransfection of
seven different HPV-16-immortalized cell lines (immortal). Each bar represents the
mean±standard error of at least 3 independent experiments and asterisks are values
that differ statistically (P≤0.05) from control (vector).
56 E.R. Vandermark et al. / Virology 425 (2012) 53–60cultures derived from ectocervical epithelium. In contrast, E6/E7
stimulated NF-kB in growing cultures of foreskin and ectocervical
cells. Cells from the transformation zone were unique in that E6/E7
inhibited NF-kB under both conﬂuent and growing conditions
(Fig. 6). Cells cultured from ectocervix or the transformation zone
grew at approximately the same rate with a doubling time of 36 to
42 h.
Regulation of clonal growth by NF-kB
NF-kB regulates a variety of pathways that control cell growth,
survival, and gene expression. Because NF-kB is known to promote
development and progression of cancer (Karin, 2006; Li et al.,
2005), we hypothesized that reduced NF-kB would inhibit cell
growth and immortalization of cervical transformation zone epithe-
lial cells by HPV-16. To examine this hypothesis, we used a dominant
negative mutant of IkBα (IkBαm) to inhibit activation (Van Antwerp
et al., 1996). IkBαm lacks sites for phosphorylation by IkB kinase so it
is not ubiquitinated and degraded. Therefore, active NF-kB subunits
do not accumulate in the nucleus. We also used an expression vector
for p65 to increase NF-kB activation. Primary cultures from the cervi-
cal transformation zone were cotransfected with the complete HPV-
16 genome plus an expression vector for either IkBαm, p65 or the
empty vector (pLZRS) as a negative control. Cells were selected for
resistance to the antibiotic G418 (the HPV-16 plasmid contains the
neomycin resistance gene) and then plated at clonal density to mea-
sure colony formation.We used a reporter gene assay to conﬁrm that
p65 stimulated NF-kB activity and that IkBαm inhibited NF-kB rela-
tive to the control pLZRS (Fig. 7A).
Unexpectedly, cells that were cotransfected with IkBαm plus
HPV-16 formed larger and more numerous colonies than cells trans-
fected with HPV-16 plus the pLZRS vector (Fig. 7B). In contrast, cells
cotransfected with HPV-16 plus the p65 expression vector formed
fewer and smaller colonies, and cells grew slowly. In six independent
experiments, IkBαm stimulated colony formation by two-fold and
p65 inhibited colony formation by 70% (Fig. 7C, HPV-16). To check
our results, we used two additional assays involving (1) infection of
normal cervical transformation zone cells with retroviruses encoding
the HPV-16 E6/E7 genes and subsequent transfection with p65 or
IkBαm and (2) transfection of seven different HPV-16 immortalized
cell lines with p65 or IkBαm. In each assay, p65 expression signiﬁ-
cantly inhibited colony formation (p≤0.05) and IkBαm signiﬁcantly
stimulated colony formation (Fig. 7C).
HPV-16 induced immortalization is regulated by NF-kB
We examined whether immortalization of cells by the complete
HPV-16 genome or the E6/E7 genes was inﬂuenced by NF-kB. Cells
from the cervical transformation zone were (1) cotransfected withthe complete HPV-16 genome plus either p65, IkBαm or the vector,
or (2) infected with HPV-16 E6/E7 retroviruses then cotransfected
with the puromycin resistance gene plus either IkBαm, p65 or vec-
tor. The negative control for immortalization consisted of cells that
did not receive HPV-16 or E6/E7. Transfected or infected/transfected
cultures were maintained in medium containing G418/puromycin to
select for stably transduced cells. The resulting colonies were pooled
and subcultured repeatedly (usually two to three times) before the
negative controls without HPV-16 became senescent.
In three independent experiments using cells from different indi-
viduals, IkBαm increased the percentage of cultures that contained
immortal cells (Table 1). This was true for immortalization by the
complete HPV16 genome or retrovirus infection with E6/E7. In con-
trast, p65 inhibited immortalization by HPV-16 or the E6/E7 genes.
To examine whether the effects of NF-kB on immortalization were
speciﬁc for HPV-16, we also performed immortalization assays
after transfection with Simian Virus 40 (SV40) DNA (Woodworth
et al., 1986). SV40 is a DNA tumor virus that resembles HPV-16 be-
cause both inactivate the retinoblastoma and p53 tumor suppressor
proteins. In three independent experiments, expression of IkBαm
signiﬁcantly increased immortalization of cervical transformation
zone cells by SV40 and the p65 expression vector decreased immor-
talization (Table 1). When data for HPV-16, E6/E7 retrovirus
Table 1
Effect of p65 or IkBαm on the frequency of immortalization of human cervical cells by
the complete HPV-16 genome, HPV16 E6/E7 genes, or SV40.
Experimental group Exp-1 Exp-2 Exp-3 total
HPV-16+vector 3/61 3/5 2/5 8/16
HPV-16+p65 0/5 2/6 1/6 3/17
HPV-16+IKBα 5/6 4/4 4/6 13/16
Retrovirus E6/E7+vector 4/5 4/6 2/4 10/15
Retrovirus E6/E7+p65 2/5 1/6 1/6 4/17*
Retrovirus E6/E7+IKBα 6/6 6/6 6/6 18/18*
SV40+vector 4/6 2/4 2/6 8/16
SV40+p65 1/5 2/6 0/5 3/16*
SV40+IKBα 4/6 5/5 4/5 13/16*
1 Number of dishes with immortal cells/total number of dishes. Each column is an
independent experiment using cells from the cervical transformation zone of different
individuals. Asterisks indicate values that were statistically different (p≤0.05) than the
vector control.
57E.R. Vandermark et al. / Virology 425 (2012) 53–60infection, and SV40 were combined, p65 inhibited immortalization
strongly (p≤0.001) and IkBαm stimulated immortalization strongly
(p≤0.001) relative to the vector-only control. These results indicate
that activation of NF-kB inhibits immortalization, but that inhibition
is not speciﬁc for HPV-16.P65 inhibits expression from the HPV-16 long control region (LCR)
Continuous expression of the HPV-16 E6 and E7 genes is re-
quired for immortalization (von Knebel Doeberitz et al., 1992),
and expression of E6/E7 is regulated by promoters and enhancers
located within the LCR, a short sequence of DNA that is upstream
of E6. We used a reporter gene assay to examine whether cotrans-
fection with p65 or IkBαm regulated expression of a luciferase re-
porter gene driven by the HPV-16 LCR. Transfection of normal
cervical transformation zone cells with p65 stimulated NF-kB
strongly and inhibited expression from the HPV-16 LCR by 60%
(Fig. 8). Transfection with IkBαm decreased NF-kB but it did not
alter HPV-16 LCR activity. These results suggest that p65 inhibits
immortalization in part by decreasing HPV gene expression, but
they do not provide evidence that IkBαm stimulates immortaliza-
tion by increasing HPV expression.0
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Fig. 8. Stimulation of NF-kB activity by transfection with p65 causes decreased expres-
sion from the HPV-16 LCR. Normal cervical transformation zone cells were cotrans-
fected with p65, IkBαm or vector (control) plus a reporter gene for either NF-kB
(left) or the HPV-16 LCR (right). Bars represent the mean±standard error of 3 exper-
iments and asterisks are values that differ statistically (P≤0.05) from control
(vector=1).Discussion
Persistent infection with high-risk HPVs and immortalization of
epithelial cells are important early events in the development of cer-
vical cancer. We found that HPV-16 E6 and E7 proteins inhibited NF-
kB activity in cells cultured from the cervical transformation zone, the
region where most cervical carcinomas develop. NF-kB serves an im-
portant role in the host immune response. Down regulation of NF-kB
might represent a unique mechanism by which HPV interferes with
innate immunity and promotes persistent infection. We also found
that inhibition of NF-kB stimulated HPV-16-induced cell proliferation
and immortalization of cells from the transformation zone. Thus, NF-
kB has the potential to act as a tumor suppressor in cervical cells.
The HPV-16 E7 and E6/E7 proteins inhibited basal and TNF-α-
inducible NF-kB activity in cells from the transformation zone. Fur-
thermore, immortalization by HPV-16 decreased expression of sever-
al β-defensins that are NF-kB-inducible cationic peptides that
contribute to innate immunity (Diamond et al., 2008). HPV-16 is
known to interfere with speciﬁc NF-kB-responsive pathways that
are important for immunity including expression of major histocom-
patibility genes (Georgopoulos et al., 2000), Toll-like receptor-9
(Hasan et al., 2007), and interferons (Nees et al., 2001; Ronco et al.,
1998). The ability of HPV-16 E6/E7 to decrease NF-kB activation is a
common denominator that might contribute to each of these re-
sponses. Our observation that inhibition NF-kB was dependent on
the Rb binding domain of E7 is consistent with the fact that Rb is im-
portant for NF-kB activation and that adenovirus E1A inhibits NF-kB
in an Rb-dependent manner (Cook et al., 2002; Takebayashi et al.,
2003).
In contrast, we observed that HPV-16 E6 altered NF-kB in a cell
type- and cell growth-dependent manner. E6 and E6/E7 stimulated
activation in foreskin and ectocervical cells that were rapidly grow-
ing. However, E6 and E6/E7 were less effective in cells from the trans-
formation zone or in slowly growing cultures. Our results are
consistent with the fact that NF-kB regulation is often dependent on
cell-type and context (Hinata et al., 2003). Conﬂicting evidence exists
about whether HPV-16 stimulates (Hussain et al., 2011; James et al.,
2006; Nees et al., 2001; Xu et al., 2010) or suppresses activation of
NF-kB (Huang and McCance, 2002; Perea et al., 2000; Spitkovsky
et al., 2002). Our observations help to clarify these results by showing
that growth rate and cell type are important determinants of whether
HPV-16 E6 or E6/E7 stimulate or inhibit NF-kB. The mechanism by
which E6 activates NF-kB is incompletely understood. The E6 protein
reduces levels of the p53 tumor suppressor protein (Scheffner et al.,
1990), and p53 decreases NF-kB activation (Webster and Perkins,
1999). In addition, the ability of the E6 protein to activate the tran-
scriptional regulator NFX1-91 or to target PDZ domains may also be
important (James et al., 2006; Xu et al., 2010).
Chronic inﬂammation and activation of NF-kB contribute to sever-
al types of human cancer (Karin, 2009). NF-kB is constitutively acti-
vated in high grade squamous intraepithelial neoplasia and cervical
cancer (Branca et al., 2006; Nair et al., 2003; Prusty et al., 2005). How-
ever, we observed that expression of HPV-16 E6/E7 and cell immor-
talization inhibited NF-kB in cells from the cervical transformation
zone. This suggests that activation of NF-kB during cervical carcino-
genesis may not be autonomous for epithelial cells. Instead, activation
may result from changes in the tumor microenvironment such as the
presence of chronic inﬂammatory cells and activated ﬁbroblasts
(Greten et al., 2004; Pikarsky et al., 2004). The latter are known to
promote inﬂammation and tumor formation in an NF-kB-dependent
manner in an HPV-16 transgenic mouse model (Erez et al., 2010).
NF-kB stimulates cell growth and survival and can function as an
oncogene. Inhibitors of NF-kB sensitize cervical cancer cells to apo-
ptosis (Venkatraman et al., 2005). Therefore, we originally hypothe-
sized that activation of NF-kB would stimulate cell growth and
immortalization. However, we observed the opposite. We found
58 E.R. Vandermark et al. / Virology 425 (2012) 53–60that activation of NF-kB in normal cervical cells inhibited clonal
growth and immortalization by HPV-16. Similarly, inhibition of NF-
kB by dominant negative IkBαm stimulated clonal growth and the
frequency of immortalization. Stimulation was observed using the
complete HPV-16 genome, the E6/E7 genes, or the tumor virus
SV40. This indicates that effects of IkBαm and p65 are not speciﬁc
for cells expressing HPV-16. Our results are consistent with the obser-
vation that p65 inhibits growth of normal human keratinocytes (Seitz
et al., 1998) and that inhibition of NF-kB promotes epidermal carcino-
genesis in mice (Dajee et al., 2003; van Hogerlinden et al., 1999). The
apparent difference in NF-kB responsiveness between normal and
cancerous cervical cells is potentially important, although our exper-
iments did not address this question.
The mechanism(s) by which NF-kB inhibits cell growth and im-
mortalization of normal cervical cells is incompletely understood. Ex-
pression of the HPV-16 E6 and E7 genes is required for continued
growth of cervical carcinoma cells and HPV-immortal cell lines (von
Knebel Doeberitz et al., 1992). The HPV-16 LCR contains a binding
site for NF-kB (Fontaine et al., 2000) and we found that p65 inhibited
expression from the HPV-16 LCR in a reporter gene assay. This sug-
gests that one mechanism by which NF-kB activation might inhibit
growth and immortalization is by decreasing HPV gene expression.
However, we also found that the IkBαm did not stimulate HPV-16
LCR activity. Thus, decreased NF-kB does not appear to promote
growth and immortalization by stimulating HPV-16 gene expression.
Additional mechanisms might contribute to the ability of NF-kB to in-
hibit cell growth and immortalization. Activation of NF-kB signaling
promotes cell senescence (Rovillain et al., 2011) and NF-kB RelA op-
poses epidermal proliferation driven by TNFR1 and JNK (Zhang
et al., 2004).
Conclusions
We show that HPV-16 E6 and E7 proteins inhibit basal and TNF-α-
inducible NF-kB activity in cells of the cervical transformation zone
where most cervical cancers develop. Decreased NF-kB activation
might represent a unique mechanism for the virus to interfere with
the host immune response and promote persistent infection. We
also show that down regulation of NF-kB stimulates clonal growth
and immortalization of cervical epithelial cells. NF-kB is a potential
target for cancer chemoprevention and therapy. Our observations
raise concerns about chronic suppression of NF-kB in patients who
have an increased risk for cervical cancer.
Materials and methods
Cell culture
Samples of cervical and oral epithelial tissue were obtained from
patients with non malignant disease by the Cooperative Human Tis-
sue Network. Cell cultures from endocervix, ectocervix or the trans-
formation zone were isolated and identiﬁed as described
(Woodworth and Simpson, 1993). Foreskins were obtained from the
nursery of the local hospital. All tissues were collected in RPMI medi-
umwith 10% fetal bovine serum plus antibiotics and used within 24 h.
Epithelial cells were isolated using a two step enzymatic digestion
(Woodworth and Simpson, 1993). Brieﬂy, each tissue was digested
for 16 h at 4 °C in dispase (BD Biosciences) and the epithelium was
removed from the underlying connective tissue by scraping. The epi-
thelial sheet was cut into 1 mm2 pieces and digested in 0.25% trypsin
at 37 °C for 10 min. Trypsinwas neutralized by addition of fetal bovine
serum and cells were collected by centrifugation at 2000xg. Normal
epithelial cells, HPV-16 immortalized cells (Woodworth et al., 1990)
and cervical carcinoma cell lines (Woodworth et al., 1995) were cul-
tured in Keratinocyte Serum-Free Medium (KSFM, Invitrogen).Retrovirus infection with HPV-16 genes
HPV genes were introduced into cultured cervical cells by infec-
tion with recombinant HPV-16 retroviruses (Halbert et al., 1991).
Secondary cultures were infected with high-titer retroviruses as de-
scribed (Woodworth et al., 1992) encoding HPV-16 E6, E7, or E6/E7
genes inserted into the vector pLXSN, which contains the neomycin
resistance gene. Retroviruses containing the p24gly mutant
(Edmonds and Vousden, 1989) have been described (Nees et al.,
2001). Infection was performed for 3 h in medium with 10 ng/ml
polybrene with rocking every 15 min. Subsequently, medium was
changed and cells grew for 24 h before cultures were split 1:3. After
24 h, infected cells were selected by growth for 2 days in KSFM con-
taining 200 μg/ml G418 and used immediately.Dual luciferase reporter gene assay
Cells were grown in 12 well plates and cotransfected with lipofec-
tamine (Invitrogen) for 3 h using either 0.5 μg of the NF-kB respon-
sive ﬁreﬂy luciferase reporter gene (Clontech) or the HPV-16 LCR
ﬁreﬂy luciferase reporter gene (Khan et al., 1997), and 0.25 μg of a
renilla luciferase reporter gene (Clontech). The latter promoter has
weak activity and served as an internal control for transfection efﬁ-
ciency. Transfected cultures were maintained in KSFM for 24 h prior
to measuring NF-kB activity using a dual luciferase assay (Promega).
Each transfection was performed in triplicate, and transfection exper-
iments were repeated at least 3 times using cells from different do-
nors. Positive and negative controls for NF-kB activation included
cotransfection with a p65 expression vector (Seitz et al., 1998) or a
vector containing the IKBαm dominant negative mutant (Van
Antwerp et al., 1996), respectively.Immortalization assay
Immortalization assays were performed after transfection with
plasmid pMHPV16d containing the complete HPV-16 genome
(Woodworth et al., 1988), the complete SV40 genome (Woodworth
et al., 1986), or infection with HPV-16 E6/E7 retroviruses
(Woodworth et al., 1992). For retrovirus-based assays, E6/E7-infected
cells were subsequently cotransfected with the puromycin resistance
gene (Clontech) plus either p65, IkBαm, or the empty vector pLZRS.
After 24 h, cells were subcultured (6×60 mm dishes experimental
group) in KSFM containing 10 ng puromycin for 2 days. Cells infected
with retroviruses containing only the pLXSN vector (lacking HPV-16
genes) served as the negative control for immortalization. For
transfection-based immortalization assays, cultures were cotrans-
fected with pMHPV16d plus the neomycin resistance gene, and either
p65, IkBαm, or pLZRS (vector). After selection for stably transfected
cells using G418, cultures were fed with fresh KSFM every two days.
Immortalization was measured by pooling the colonies in each dish
and subculturing cells continually. Cells transfected with the neomy-
cin resistance gene alone served as a negative control for immortali-
zation. These cells became senescent after 2 or 3 additional
passages. Cells transfected with a plasmid encoding the SV40 genome
served as a control for determining speciﬁcity of effects for HPV-16.Clonal growth assay
Cells were stably transduced with HPV-16 DNA or E6/E7 retrovi-
ruses plus p65, IkBαm or pLZRS expression plasmids as described
for immortalization assays. Cultures were maintained in KSFM for
14 days (retrovirus-infected) or 21 days (transfected). After colonies
became visible, dishes were ﬁxed with formalin and stained with
Giemsa to identify colonies. A colony was deﬁned as 50 or more cells.
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RNA was extracted from ﬁve different primary cervical cultures
and four HPV-immortalized cell lines using Trizol (Invitrogen). Cel-
lular DNA was removed using Turbo RNA-Free DNAse (Ambion) and
RNA was reverse transcribed using Superscript First Strand kit (Invi-
trogen). No RT controls were included to conﬁrm absence of cell
DNA. Real-time PCR was performed using an iCycler IQ (Bio-Rad)
using triplicate reactions (50 μl) containing 25 μl of 2x SYBR-Green
Supermix, 0.4 μM of each forward and reverse primer, and 1 μl
cDNA. Primers were: human β-defensin-1 forward GGGAGTGACCA
GAAGAAATGA and reverse TTGGCCCAAAGGAGGTAT, human β-
defensin-2 forward CTGGAACAAAATGCTGCAAA and reverse
TGGTTTACATGTCGCACGTC, human β-defensin-3 forward TCCAAAG
GAGGAACAGATCG and reverse GGCATTTCCACACTTTACAACA,
human β-defensin-5 forward TGTCTGTGAGTCGTGCAAGC and re-
verse CTGCAGCAGAGAAAGTTCAGC, human β-defensin-7 forward
AGGTCACTGTGAAGCCGAAT and reverse GCAGCCAGAGAATCTT
CACC, β-actin forward GGACTTCGAGCAAGAGATGG and reverse
AGCACTGTGTTGGCGTACCAG, and RPL38 forward CGAAAG
GATGCCGGGTCTGT and reverse TCAGTTCCTTCACTGCCAA.
Reactions were performed for 40 cycles and melting temperature
analysis was conducted on each sample to check speciﬁcity of product.
Relative expression was calculated using the Pfafﬂ method (Pfafﬂ,
2001). Housekeeping genes (β-actin, and RPL38) were examined for
normalization and β-actin was chosen because immortalization did
not alter expression.
Statistical analysis
One way analysis of variance (ANOVA) was used to compare the
means of multiple experimental groups when data was distributed
normally, and the Kruskal-Wallis test was used for comparisons
when the distribution was not normal. Tukey's multiple comparison
test was used to compare differences between each pair of means.
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